Serum GP88 as a predictive biomarker for hepatocellular carcinoma in patients with viral hepatitis C after direct-acting antiviral agents.

Hidekazu Ishida,Masao Takemura,Atsushi Suetsugu,Takafumi Naiki,Takuji Tanaka,Tomita Eiichi,Ginette Serrero,Hidetoshi Matsunami,Yasuko Yamamoto,Kuniaki Saito

Serum GP88 as a predictive biomarker for hepatocellular carcinoma in patients with viral hepatitis C after direct-acting antiviral agents.

2021

Hidekazu Ishida
Masao Takemura
Atsushi Suetsugu
Takafumi Naiki
Takuji Tanaka
Tomita Eiichi
Ginette Serrero
Hidetoshi Matsunami
Yasuko Yamamoto
Kuniaki Saito

BackgroundProgranulin (GP88) is an 88-kDa glycoprotein growth factor with important biological effects in tumorigenesis and tumour survival. We investigated the usefulness of measuring serum GP88 c...

Keywords:

Liver disease
Carcinogenesis
Cancer research
Hepatocellular carcinoma
Growth factor
Viral hepatitis
direct acting
Glycoprotein
in patient
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations